Dosing
Wegovy injection dosage chart: a guide to the label
Wegovy is no longer one formulation with one maximum dose. The current label includes weekly injections, Wegovy HD 7.2 mg, and daily tablets. This chart explains the standard injection schedule.
How to read a dosage chart
A titration chart describes a labeled schedule, not an instruction to change your own treatment. Starter doses help introduce the medicine; the prescriber selects a maintenance dose according to the indication, response, and tolerability. Calendar weeks do not override side effects or individualized instructions.
Milligrams measure the medicine dose. Milliliters measure liquid volume, and syringe units measure markings on a particular syringe. They are not interchangeable. Never use a brand-name chart to convert a compounded vial into syringe units: concentrations differ, and the pharmacist must provide product-specific instructions.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
Labeled schedule
Dose escalation can be delayed when a dose is not tolerated. The HD option does not replace the starter schedule and is not a universal maintenance dose for every indication or age group. Cardiovascular-risk reduction, adolescent treatment, and MASH require attention to their own labeled dosing and population limits.
| Stage or indication | Dose | Meaning |
|---|---|---|
| Weeks 1–4 | 0.25 mg weekly | Starting step |
| Weeks 5–8 | 0.5 mg weekly | Escalation |
| Weeks 9–12 | 1 mg weekly | Escalation |
| Weeks 13–16 | 1.7 mg weekly | Escalation or indication-specific maintenance |
| Week 17 onward | Usually 2.4 mg weekly | Maintenance depends on indication and tolerability |
| Selected adults needing further weight reduction | Wegovy HD 7.2 mg weekly | Only after at least 4 weeks at 2.4 mg and prescriber assessment |
Sources: Wegovy prescribing information, including tablets and Wegovy HD
Missed doses and other instructions
For one missed injection, take it if the next scheduled dose is more than 2 days away; skip it if the next dose is less than 2 days away. Ask your clinician or pharmacist about the exact 2-day boundary. The June 2026 prescribing information instructs reinitiation of escalation at a lower dose after 2 or more consecutive missed injections. Arrange that restart with the prescriber.
The device you receive matters. Single-dose pens, multidose pens, prefilled syringes, and vials do not use one universal injection technique. Review the Instructions for Use supplied with your product, and request training when a pharmacy changes the presentation.
Sources: Wegovy prescribing information, including tablets and Wegovy HD
Safety before any dose change
These medicines have boxed warnings about thyroid C-cell tumors observed in rodents; whether the same risk occurs in humans is unknown. Personal or family history of medullary thyroid carcinoma or MEN 2 is a contraindication. This is different from saying that every thyroid condition prevents treatment.
Review severe stomach problems, previous pancreatitis, gallbladder disease, kidney problems, diabetes-related eye disease, pregnancy plans, and all medicines with your prescriber. Insulin or sulfonylureas can increase the risk of low blood sugar when combined with these treatments. Vomiting and diarrhea can cause dehydration and kidney injury.
Severe persistent abdominal pain, inability to keep fluids down, or signs of an allergic reaction require prompt medical assessment. Do not increase a dose to overcome slow weight loss or copy another person's prescription. Tell the anesthesia team about treatment before procedures because delayed gastric emptying can affect aspiration risk.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Ozempic prescribing information · Zepbound prescribing information · Mounjaro prescribing information
What a slower escalation means
The standard injection schedule builds exposure in stages to help with tolerability. If a dose is not tolerated, the label allows delaying escalation. That is different from independently dividing a pen dose, using a homemade microdosing schedule, or advancing faster because appetite has returned. The prescriber should name the revised step and timing, and the pharmacy should supply the correct presentation.
During each stage, record symptoms that affect meals, fluids, or daily activities, along with the date of the most recent injection. The benefit of treatment is assessed over time. A quieter appetite during the first week followed by a more familiar appetite later in the week does not establish that the dose has failed or that an extra injection is appropriate. Severe or persistent symptoms need assessment even during a familiar stage.
Sources: Wegovy prescribing information, including tablets and Wegovy HD
Read maintenance in the context of the indication
Wegovy's name now covers standard injection, tablets, and the higher-dose HD option. Age and indication matter within that product family. An adult seeking additional weight reduction after established treatment at 2.4 mg has a different dose conversation from an adolescent or an adult treated for noncirrhotic MASH with F2–F3 fibrosis. The HD option is not simply the new last row for everyone.
Ask the clinician to write the treatment purpose next to the intended maintenance dose. That helps distinguish a labeled option from a decision made for another indication. It also makes insurance conversations clearer: authorization for one presentation is not necessarily authorization for every Wegovy product. A pharmacy substitution or an online price comparison should not silently change the formulation or treatment plan.
Sources: Wegovy prescribing information, including tablets and Wegovy HD
Why a restart may return to an earlier step
Imagine a person who previously tolerated maintenance treatment but has missed several consecutive injections because coverage lapsed. Their old dose is historical information, not proof that restarting it is still tolerable. The current label instructs reinitiation of escalation at a lower dose after two or more consecutive missed injections. Arrange the dose and timing with the prescriber before using remaining supplies.
For a single late dose, the label instead uses the time remaining before the next scheduled injection. That is why the instructions differ from Ozempic's five-day window despite both containing semaglutide. Give the pharmacist the actual dates and times rather than saying only that a dose is "a few days late." If symptoms, pregnancy planning, or a procedure caused the interruption, discuss that reason before restarting.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Ozempic prescribing information
Sources and evidence
Sources checked October 2, 2026. Prescribing information supports medication facts; provider pages support advertised services. Offers and labels can change.